New lipid lowering drugs help patients reduce LDL cholesterol supriya kashyap kashyap3 Aug 2016 12:49 PM ISTA recent analysis indicates that adding new therapies called anti-PCSK9 antibodies to other lipid-lowering treatments can help patients lower their...
New drug in combo with statins can cut cholesterol: NEJM supriya kashyap kashyap19 March 2017 1:47 PM ISTWashington : A new class of cholesterol-lowering drug can help patients cut their risk of cardiovascular disease, stroke and heart attack.In a trial...
No Evidence of Cognitive Issues When Evolocumab Added to Statin Therapy: ACC 2017 supriya kashyap kashyap29 March 2017 12:45 PM ISTWashington : There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with...
Want to lower LDL Cholesterol further, add Evolocumab & PCSK9 Inhibitors Dr. Kamal Kant Kohli Kohli24 Oct 2017 8:00 PM ISTPatients who need additional lowering of low‐density lipoprotein‐cholesterol (LDL‐C) despite statin therapy may benefit from additional lipid‐lowering...
Evolocumab approved to Prevent Heart Attack And Stroke Dr. Kamal Kant Kohli Kohli3 Dec 2017 7:30 PM ISTU.S. Food and Drug Administration (FDA) approved Evolocumab as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary...
PCSK9 inhibitors beneficial for patients with high lipoprotein(a) levels Medha Baranwal Baranwal23 May 2018 8:00 PM ISTPCSK9 inhibitors reduced lipoprotein(a) levels and that patients starting with higher Lp(a) levels appeared to derive greater absolute benefit from...
Best Dose of Evolocumab for stable LDL-Cholesterol reduction- Check it out Vinay Singh singh4 Jun 2018 8:25 PM ISTScott M. Wasserman at Thousand Oaks, CA, USA and associates conducted a study to ascertain the best dose of Evolocumab for stable LDL-Cholesterol...
Lower the LDL cholesterol level, lower is the risk to heart : JAMA Medha Baranwal Baranwal5 Aug 2018 8:28 PM ISTIn a new study Researchers have found that lower the LDL level, lower is the risk to the heart. Therefore there is no need to be scared of lowering...
PCSK9 inhibitor Evolocumab safely cuts LDL cholesterol across all stages of CKD Deepanjana Sarkar17 Jun 2019 8:20 PM ISTPCSK9 inhibitor, Evolocumab is clinically effective and safe for lowering Low-density lipoprotein cholesterol, LDL cholesterol levels across all...
Controlling High LDL- Cholesterol: Understanding role of PCSK9 Inhibitors in Dyslipidemia Management-Dr Jamshed J Dalal Deepanjana Sarkar15 July 2019 7:02 PM ISTDyslipidemia is an elevation of plasma cholesterol, triglycerides, or both, or a low HDL cholesterol level that contributes to the development of...
Evolocumab significantly reduces LDL-C in ACS patients: JACC Medha Baranwal Baranwal26 Sept 2019 8:20 PM ISTSwitzerland: Evolocumab, potent low-density lipoprotein cholesterol-lowering drug, may cause early reduction of LDL-cholesterol levels in patients...
Evolocumab effectively prevents cardiovascular events in patients of peripheral artery disease Anjali Nimesh Nimesh16 Nov 2017 7:30 PM ISTPatients with peripheral artery disease (PAD) are at high risk of heart attack, stroke and cardiovascular death. In addition, PAD patients can suffer...
